IP Library Granted Patent US 7,241,897
Granted Patent B2
US 7,241,897 · App. 10/761,906 · Granted Jul 10, 2007

Process for preparing cyanine dye labeling reagents

Assignee: Enzo Life Sciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,241,897
App. No.
10/761,906
Granted
Jul 10, 2007
Kind
B2
Abstract

This invention provides for labeling reagents, labeled targets and processes for preparing labeling reagents. The labeling reagents can take the form of cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes. These labeling reagents are useful for labeling probes or targets, including nucleic acids and proteins. These reagents can be usefully applied to protein and nucleic acid probe based assays. They are also applicable to real-time detection processes.

Claims (22)

1. A process for preparing a cyanine dye labeling reagent, said process comprising the steps of:

(a) providing:

(i) a first intermediate compound comprising:

wherein X 1 comprises carbon, oxygen, nitrogen or sulfur; and

(ii) a second intermediate compound comprising:

wherein X 2 comprises carbon, oxygen, nitrogen or sulfur;

wherein at least one of R 1 through R 10 comprises a reactive group capable of forming a carbon-carbon linkage with a target, and

(iii) linking reagents suitable for linking said first intermediate compound and said second intermediate compound;

(b) forming a reaction mixture comprising said first intermediate compound (i), said second intermediate compound (ii), and said linking reagents under conditions to link (i) and (ii) to form

wherein at least one of R 1 through R 10 comprises a reactive group capable of forming a carbon-carbon linkage with a target, wherein said reactive group comprises an alkene group, an alkyne group, or a metallo-organic compound, and wherein n is an integer of 1, 2 or 3, and wherein X 1 and X 2 independently comprise carbon, oxygen, nitrogen or sulfur.

2. The process of claim 1 , wherein R1 through R10 independently comprise hydrogen, C 1 -C 6 alkyl, a C 1 -C 4 alkyl group having a hydrophilic substituent comprising sulfonate, carboxylate, hydroxyl, substituted amines and quaternary amines, aliphatic, alkenes, alkynes, charged or polar groups, or combinations of any of the foregoing.

3. The labeling reagent of claim 1 , wherein said metallo-organic compound comprises mercury, zinc, copper or platinum.

4. The labeling reagent of claim 1 , wherein said metallo-organic compound comprises an alkene group or an alkyne group.

5. The process of claim 1 , wherein said reactive group attached to said compound formed in step b further comprises a backbone that comprises at least two consecutive peptide bonds.

6. The process of claim 5 , wherein at least one of said two consecutive peptide bonds are separated by a single atom.

7. The process of claim 6 , wherein said single atom comprises C, N, S, O or P.

8. The process of claim 5 , wherein said backbone comprises one or more carbon atoms.

9. The process of claim 5 , wherein said backbone comprises at least one non-carbon atom.

10. The process of claim 9 , wherein said non-carbon atom comprises sulfur, oxygen or nitrogen.

11. The process of claim 5 , wherein said backbone further comprises at least one additional moiety comprising peptide bonds, amino acids, aliphatic chains from C 1 through C 20 , alkene groups, alkyne groups, saturated or unsaturated or partially saturated rings, heterocyclic rings and sugars.

12. The process of claim 5 , wherein said backbone comprises a di-peptide or an oligo-peptide.

13. The process of claim 12 , wherein said di-peptide or oligo-peptide comprises (glycine) 2 or (glycine) 4 .

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2015
From: STAVRIANOPOULOS, JANNIS G.; RABBANI, ELAZAR
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 036771/0058 →
Continuity (2)
Division 1009607500 · Mar 12, 2002
Related Publication 20040203038A1 · Oct 14, 2004